Gene · 10850
Papers2,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tissue-Specific Metabolic Reprogramming in Innate Lymphoid Cells and Its Impact on Disease. | Immune Netw | 2025 | 40078781 | PubTator, text mining | PubMed |
| Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome-Wide Mendelian Randomization and Colocalization Analysis. | Cardiovasc Ther | 2025 | 40026415 | PubTator, text mining | PubMed |
| Causal Association Between Inflammatory Factors and Hypertrophic Scar: A Two-Sample Mendelian Randomization Study. | J Cosmet Dermatol | 2025 | 40013460 | PubTator, text mining | PubMed |
| Association between plasma cytokine levels and multiple neuroimaging modalities in mild cognitive impairment. | J Alzheimers Dis | 2025 | 39956962 | PubTator, text mining | PubMed |
| Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination. | Clin Transl Immunology | 2025 | 39872402 | PubTator, text mining | PubMed |
| Investigating causal relationship among inflammatory cytokines and oropharyngeal cancer: Mendelian randomization. | Discov Oncol | 2025 | 39869291 | PubTator, text mining | PubMed |
| Integrative deep immune profiling of the elderly reveals systems-level signatures of aging, sex, smoking, and clinical traits. | EBioMedicine | 2025 | 39862806 | PubTator, text mining | PubMed |
| Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in Apc1638N/+ mice. | Aging (Albany NY) | 2025 | 39792466 | PubTator, text mining | PubMed |
| Lipid nanoparticles encapsulating both adjuvant and antigen mRNA improve influenza immune cross-protection in mice. | Biomaterials | 2025 | 39724768 | PubTator, text mining | PubMed |
| Augmented IFNγ producing ILC1 and IL 17 producing ILC3 in pemphigus vulgaris: Plausible therapeutic target. | Cell Immunol | 2025 | 39718308 | PubTator, text mining | PubMed |
| Nasal secretions trace epithelial type 2 response to allergen-specific immunotherapy. | Rhinology | 2025 | 39660695 | PubTator, text mining | PubMed |
| Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer. | JTO Clin Res Rep | 2025 | 39619775 | PubTator, text mining | PubMed |
| Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma. | Front Immunol | 2024 | 39687621 | PubTator, text mining | PubMed |
| Causal relationship between 41 inflammatory factors, circulating white blood cells, and pruritus: A 2-sample bidirectional Mendelian randomization study. | Medicine (Baltimore) | 2024 | 39686490 | PubTator, text mining | PubMed |
| Tacrolimus versus hydrocortisone in management of atopic dermatitis in children, a randomized controlled double-blind study: New insights on TARC, CTACK, TSLP, and E-selectin. | Immun Inflamm Dis | 2024 | 39588929 | PubTator, text mining | PubMed |
| Genetically predicted serum ferritin mediates the association between inflammatory cytokines and non-alcoholic fatty liver disease. | Front Endocrinol (Lausanne) | 2024 | 39583964 | PubTator, text mining | PubMed |
| A causal association between chemokines and the risk of lung cancer: a univariate and multivariate mendelian randomization study. | J Cardiothorac Surg | 2024 | 39516747 | PubTator, text mining | PubMed |
| Systemic inflammatory regulators are associated with two common types of neuropathic pain: A bidirectional Mendelian randomization study. | Int Immunopharmacol | 2024 | 39471697 | PubTator, text mining | PubMed |
| Circulating levels of cytokines and risk of urologic cancers: a two-sample Mendelian randomization study. | BMC Cancer | 2024 | 39390542 | PubTator, text mining | PubMed |
| Association between aortic calcification and cytokine levels in patients with peripheral artery disease. | Clin Transl Sci | 2024 | 39344403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10850/papers?page=6